Why?
Let’s treat localized disease, locally.
By creating a new medical modality of remote-controlled micro-robots called Bionauts we can transform the way the biopharmaceutical industry develops treatments, allowing us to engineer the therapeutic index for efficacy and maintain safety.
Why?Therapies weren’t local, until now.
We have been treating diseases in the deep centers of the brain with conventional systemic therapies, because we lacked a way of delivering them locally, until now. The Bionaut platform allows safe, reliable access to midbrain and other sensitive brain circuitry.
Why?The drug access & exposure challenge
Drug access and exposure at the disease loci remains a major challenge to successful development of therapies for many brain conditions.
Why?The delivery technology challenge
Bionauts deliver drugs locally to generate efficacy and avoid side effects and toxicity from systemically delivered drugs.
Why?
Direct access to precise body locations transforms the way we understand & treat human health.
Bionaut will enable us to measure, analyze and treat human diseases in a way not attainable with existing technical approaches.
